Fibrinolytic Activity in Patients Receiving Long-Term Anticoagulants for Myocardial Infarction

Biggs R. Macfarlane R. G. (1957). Human blood coagulation and its disorders, 2nd edition, p. 389. Oxford: Blackwell.

Clement W. E. McNicol G. P. (1959). The preparation and use of ¹³¹ I-tagged fibrinogen to demonstrate fibrinolysis. J. Clin. Path., 12, 544.

Holborn R. R. (1951). In Coagulation of the blood. Methods of study. edited by Tocantins L. M. . New York and London: Grune and Stratton.

Hume R. (1958). Fibrinolysis in myocardial infarction. Brit. Heart J., 20, 15.

Hume R. (1961). The relationship to age and cerebral vascular accidents of fibrin and fibrinolytic activity. J. clin. Path., 14, 167.

Hume R. (1965). Fibrinolytic activity and thyroid function. Brit. med. J., 1, 686.

James D. C. O. Drysdale J. Billimoria J. D. Wheatley D. Gavey C. J. Maclagan N. F. (1961). Lipaemia and blood-coagulation defects in relation to ischaemic heart-disease. Lancet, 2, 789.

Janiakawa A. Kotlarek-Haus S. Potoczek S. Tkaczewski W. (1958). Badania nad przyrostem azotu niebialkowego w czasie krzepniecia i fibrinolizy w miazdzycy. Polski tygod. lek., 13, 921.

Katz A. M. McDonald L. Davies B. Edgill M. (1963). Fibrinolysis and blood coagulation in ischaemic heart-disease. Lancet, 1, 801.

Lackner H. Merskey C. (1960). Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin. Brit. J. Haemat., 6, 402.

McKenzie J. M. (1960). Quoted by Guest M. Mason Celander D. R. Proceedings of Conference on Thrombolytic Agents, April, 8–9, 1960, p. 75. Chicago, Illinois.

Merskey C. Gordon H. Lackner H. (1958). Diet, blood cholesterol, blood coagulation and fibrinolysis in relation to coronary heart-disease: an inter-racial study. S. Afr. med. J., 34, 855.

Merskey C. Gordon H. Lackner H. (1960). Blood coagulation and fibrinolysis in relation to coronary heart-disease. Brit. med. J., 1, 219.

Nestel P. J. (1959). Fibrinolytic activity of the blood in intermittent claudication. Lancet, 2, 373.

Nestel P. J. (1960). The relationship between blood fibrinolytic activity, serum lipoproteins and serum cholesterol in atherosclerotic vascular disease. Aust. Ann. Med., 9, 234.

Niewiarowska M. Wegrzynowicz Z. (1959). Influence of dicoumarol derivatives on plasma fibrinolytic system. Thromb. Diath. haemorrh., 3, 279.

Ogston D. (1961). The effect of phenindione on plasma fibrinolytic activity. Scot. med. J., 6, 565.

Ogston D. McDonald G. A. Fullerton H. W. (1962). The influence of anxiety on tests of blood coagulability and fibrinolytic activity. Lancet, 2, 521.

Ogston D. (1962). Serum mucoproteins and plasma fibrinolytic activity in coronary-artery disease. Brit. med. J., 1, 1242.

Ogston D. Fullerton H. W. (1965). Plasma fibrinolytic activity following recent myocardial infarction. Lancet, 2, 99.

Pearson H. E. S. Joseph J. (1963). Stress and occlusive coronary-artery disease. Lancet, 1, 415.

Raynaud R. Brochier M. Griguer F. (1961). Fibrinolytic activity of the plasma in atherosclerosis. Bull. Soc. Med. Hôp. Paris, 77, 576–8.

Røgel J. (1959). A study of the fibrinolytic activity in thrombotic diseases. Acta med. scand., 164, 81.

Sarkar N. (1961). Reduced fibrinolytic activity of atherosclerotic sera caused by an increase in low-density lipoproteins in blood. Nature, Lond., 189, 929.

Sawyer W. D. Fletcher A. P. Alkjaersig H. Sherry S. (1960). Studies on the thrombolytic activity of human plasma. J. clin. Invest., 39, 426.

Swan H. T. (1963). Fibrinolysis related to age in man. Brit. J. Haemat., 9, 311.